HRASLS3 (PLA2G16) (2-15) Goat Polyclonal Antibody

CAT#: AP22557PU-N

HRASLS3 (PLA2G16) (2-15) goat polyclonal antibody, Aff - Purified

Product Images

Human Brain, Cortex (formalin-fixed, paraffin-embedded) stained with PLA2G16 antibody at 5 ug/ml followed by biotinylated anti-goat IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.

Specifications

Product Data

• Applications: ELISA, IHC
• Recommended Dilution: ELISA: 1/128000.
  Immunohistochemistry on Paraffin Sections: 5 µg/ml.
• Reactivities: Human, Monkey, Rabbit
• Host: Goat
• Clonality: Polyclonal
• Immunogen: Synthetic peptide from the N-terminus of human PLA2G16 (NP_009000.2)
• Specificity: This antibody detects HRAS-like suppressor 3 / HRASLS3 (2-15).
• Formulation: Tris saline, pH 7.3 containing 0.02% sodium azide as preservative and 0.5% BSA as stabilizer
  State: Aff - Purified
  State: Liquid purified Ig fraction
• Concentration: 0.5 mg/ml
• Purification: Immunoaffinity chromatography
• Gene Name: Homo sapiens phospholipase A2 group XVI (PLA2G16), transcript variant 2
• Database Link:
  Entrez Gene 24913 RatEntrez Gene 225845 MouseEntrez Gene 11145 Human
• Background: Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue By similarity. N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.
• Synonyms: HREV107, NY-REN-65, HREV107-3

Reference Data

• Protein Families: Druggable Genome, Transmembrane